OBJECTIVE: We analyzed, in vivo, whether the establishment of blood supply to implanted scaffolds can be accelerated by inosculation of an in situ-preformed microvascular network with the host microvasculature. BACKGROUND: A rapid vascularization is crucial for the survival of scaffold-based transplanted tissue constructs. METHODS: Poly-lactic-glycolic acid scaffolds were implanted into the flank of balb/c or green fluorescent protein (GFP)-transgenic mice for 20 days to create in situ a new microvascular network within the scaffolds. The prevascularized scaffolds were then transferred into the dorsal skinfold chamber of isogeneic recipient mice. Nonvascularized poly-lactic-glycolic acid scaffolds served as controls. Vascularization, blood perfusion, and cell survival of the implants were analyzed over 14 days using intravital fluorescence microscopy, histology, and immunohistochemistry. RESULTS: Our results demonstrate that establishment of blood perfusion of prevascularized scaffolds is significantly accelerated and improved (136.7 +/- 23.2 pl/s) when compared with controls (6.9 +/- 1.9 pl/s), because the in situ-preformed microvessels were reperfused by forming interconnections to the host microvasculature. Apoptotic cell death within the implants was found only during the first 3 to 6 days after scaffold implantation during lack of blood perfusion, but not during the further 14-day observation period. CONCLUSIONS: Inosculation of in situ-preformed functional blood vessels represents a promising approach to improve the blood supply to implanted tissue constructs.
OBJECTIVE: We analyzed, in vivo, whether the establishment of blood supply to implanted scaffolds can be accelerated by inosculation of an in situ-preformed microvascular network with the host microvasculature. BACKGROUND: A rapid vascularization is crucial for the survival of scaffold-based transplanted tissue constructs. METHODS:Poly-lactic-glycolic acid scaffolds were implanted into the flank of balb/c or green fluorescent protein (GFP)-transgenic mice for 20 days to create in situ a new microvascular network within the scaffolds. The prevascularized scaffolds were then transferred into the dorsal skinfold chamber of isogeneic recipient mice. Nonvascularized poly-lactic-glycolic acid scaffolds served as controls. Vascularization, blood perfusion, and cell survival of the implants were analyzed over 14 days using intravital fluorescence microscopy, histology, and immunohistochemistry. RESULTS: Our results demonstrate that establishment of blood perfusion of prevascularized scaffolds is significantly accelerated and improved (136.7 +/- 23.2 pl/s) when compared with controls (6.9 +/- 1.9 pl/s), because the in situ-preformed microvessels were reperfused by forming interconnections to the host microvasculature. Apoptotic cell death within the implants was found only during the first 3 to 6 days after scaffold implantation during lack of blood perfusion, but not during the further 14-day observation period. CONCLUSIONS: Inosculation of in situ-preformed functional blood vessels represents a promising approach to improve the blood supply to implanted tissue constructs.
Authors: Sean M White; Chelsea R Pittman; Ryan Hingorani; Rajan Arora; Tatiana V Esipova; Sergei A Vinogradov; Christopher C W Hughes; Bernard Choi; Steven C George Journal: Tissue Eng Part A Date: 2014-06-30 Impact factor: 3.845
Authors: Sean M White; Ryan Hingorani; Rajan P S Arora; Christopher C W Hughes; Steven C George; Bernard Choi Journal: Tissue Eng Part C Methods Date: 2012-05-21 Impact factor: 3.056
Authors: Jeannette Rudzitis-Auth; Sophia A Fuß; Vivien Becker; Michael D Menger; Matthias W Laschke Journal: Br J Pharmacol Date: 2020-04-12 Impact factor: 8.739